Collagen Matrix News
Collagen Matrix, Inc. Receives FDA 510(k) Clearance of a Bioactive Moldable Bone Graft Matrix
OAKLAND, New Jersey, April 12, 2019 – Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based medical devices announced today
Collagen Matrix, Inc. Names Gregory Pomrink as Vice President, Research and Development
OAKLAND, New Jersey, March 21, 2018 – Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based
Collagen Matrix Launches OssiMend® Spine and DuraMatrix® Dural Repair Products in Asia
OAKLAND, New Jersey, February 26, 2018 – Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based
Collagen Matrix Celebrates 20 Years of Science, Technology and Innovation
OAKLAND, New Jersey, July 17, 2017 – It started with an idea that transformed into a success story, 20 years in the making. Today,
Collagen Matrix, Inc. Names Oystein Valberg as Chief Financial Officer
Collagen Matrix, Inc., which advances the science of tissue repair and regeneration by designing, developing and manufacturing collagen and mineral based medical devices that support
Collagen Matrix, Inc. Names Bill Messer as Vice President, Sales and Marketing
Collagen Matrix, Inc., (“Collagen Matrix”) the driving force in the design, development and manufacturing of collagen and mineral based medical devices for tissue repair
Shu-Tung Li to be Inducted Into The AIMBE College of Fellows
Collagen Matrix, Inc., the driving force in the design, development and manufacturing of collagen and mineral based medical devices for tissue repair and regeneration
Collagen Matrix, Inc. Selected to Participate in FDA’s Experiential Learning Program
Collagen Matrix, Inc. (Collagen Matrix) a leading provider of high quality products and technology used in tissue repair and regeneration announced today it has